Solventum Corporation SOLV
89.50
0.91
1.03%
as of 25 Sep
- Market cap
- $15.1B
- P/E
- 10.9×
Follow SOLV
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Solventum Corporation (SOLV) P/B ratio
As of 25 September 2026, Solventum Corporation (SOLV) trades at a P/B ratio of 3.2×. Over the past ten years it has ranged from 1.0× (March 2024) to 4.9× (February 2025); the current reading is higher than 50% of that period. That is above the Medical Instruments & Supplies industry median of 2.8× and above the Healthcare sector median of 2.5×.
P/B ratio, daily
Annual
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 2.7× | (29.35%) |
| FY2024 | 3.9× | 226.50% |
| FY2023 | 1.2× | 0.00% |
| FY2022 | 1.2× | — |
Quarterly
| Period | P/B ratio | Change |
|---|---|---|
| Jun 2026 | 2.8× | 21.30% |
| Mar 2026 | 2.3× | (16.22%) |
| Dec 2025 | 2.7× | 7.05% |
| Sep 2025 | 2.6× | (29.55%) |
| 10 more quarters | Free account |
Against its own ten years
Low 1.0×
High 4.9×
Ten-year median
3.2×
Current reading's percentile
50
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| COO The Cooper Companies, Inc. compare | 1.3× |
| ALC Alcon compare | 1.5× |
| AVTR Avantor, Inc. compare | 1.8× |
| BAX Baxter International Inc. compare | 2.0× |
| ALGN Align Technology, Inc. compare | 2.5× |
| ATR AptarGroup, Inc. compare | 3.0× |
| SOLV Solventum Corporation | 3.2× |
| RGEN Repligen Corporation compare | 5.1× |
| WST West Pharmaceutical Services, Inc. compare | 8.8× |
| Medical Instruments & Supplies industry median | 2.8× |
| Healthcare sector median | 2.5× |
| Market median | 1.8× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on SOLV
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement